Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label, single sequence, repeat dose study to investigate the effects of GSK 189075 [remogliflozin etabonate] on the pharmacokinetics of an oral contraceptive pill [ethinylestradiol/norethisterone] when coadministered to healthy female volunteers.

Trial Profile

An open label, single sequence, repeat dose study to investigate the effects of GSK 189075 [remogliflozin etabonate] on the pharmacokinetics of an oral contraceptive pill [ethinylestradiol/norethisterone] when coadministered to healthy female volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Ethinylestradiol/norethisterone; Remogliflozin etabonate
  • Indications Pregnancy
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 03 Feb 2010 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top